$177 Million is the total value of Sio Capital Management, LLC's 45 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 275.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $11,557,000 | +65.8% | 325,823 | +89.8% | 6.52% | +80.2% |
| AET | Buy | AETNA INC | $10,479,000 | +30.4% | 58,089 | +15.0% | 5.91% | +41.8% |
| ANTM | Buy | ANTHEM INC | $10,001,000 | +292.5% | 44,446 | +231.2% | 5.64% | +326.6% |
| KURA | Buy | KURA ONCOLOGY INC | $5,998,000 | +45.5% | 392,027 | +42.2% | 3.38% | +58.2% |
| ISRG | Buy | INTUITIVE SURGICAL INCput | $5,839,000 | +123.3% | 16,000 | +540.0% | 3.29% | +142.7% |
| VKTX | New | VIKING THERAPEUTICS INC | $5,076,000 | – | 1,250,250 | +100.0% | 2.86% | – |
| ASGN | New | ON ASSIGNMENT INCcall | $4,949,000 | – | 77,000 | +100.0% | 2.79% | – |
| CAH | New | CARDINAL HEALTH INCcall | $4,902,000 | – | 80,000 | +100.0% | 2.76% | – |
| TNET | New | TRINET GROUP INCcall | $4,877,000 | – | 110,000 | +100.0% | 2.75% | – |
| PINC | New | PREMIER INCcall | $4,670,000 | – | 160,000 | +100.0% | 2.63% | – |
| WCG | New | WELLCARE HEALTH PLANS INC | $4,666,000 | – | 23,200 | +100.0% | 2.63% | – |
| LLY | New | ELI LILLY AND CO | $4,552,000 | – | 53,900 | +100.0% | 2.57% | – |
| UNH | New | UNITEDHEALTH GROUP INCcall | $4,409,000 | – | 20,000 | +100.0% | 2.49% | – |
| EBS | Buy | EMERGENT BIOSOLUTIONS INC | $4,254,000 | +16.5% | 91,533 | +1.4% | 2.40% | +26.7% |
| BSX | New | BOSTON SCIENTIFIC CORP | $3,712,000 | – | 149,752 | +100.0% | 2.09% | – |
| HCA | New | HCA HEALTHCARE INCcall | $3,698,000 | – | 42,100 | +100.0% | 2.09% | – |
| PFE | New | PFIZER INCput | $3,622,000 | – | 100,000 | +100.0% | 2.04% | – |
| MD | New | MEDNAX INC | $3,025,000 | – | 56,598 | +100.0% | 1.71% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $2,508,000 | – | 19,000 | +100.0% | 1.41% | – |
| LGND | New | LIGAND PHARMACEUTICALS INCcall | $2,465,000 | – | 18,000 | +100.0% | 1.39% | – |
| XNCR | Buy | XENCOR INC | $2,411,000 | +217.7% | 109,981 | +232.3% | 1.36% | +245.2% |
| NTUS | New | NATUS MEDICAL INCput | $2,025,000 | – | 53,000 | +100.0% | 1.14% | – |
| MEIP | New | MEI PHARMA INC | $1,737,000 | – | 826,913 | +100.0% | 0.98% | – |
| ODT | New | ODONATE THERAPEUTICS INC | $1,250,000 | – | 50,000 | +100.0% | 0.70% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $1,186,000 | – | 35,000 | +100.0% | 0.67% | – |
| ISRG | New | INTUITIVE SURGICAL INC | $1,095,000 | – | 3,000 | +100.0% | 0.62% | – |
| MYOV | New | MYOVANT SCIENCES LTD | $923,000 | – | 73,054 | +100.0% | 0.52% | – |
| CPSI | New | COMPUTER PROGRAMS AND SYSTEMS INC | $738,000 | – | 24,543 | +100.0% | 0.42% | – |
| CCXI | Buy | CHEMOCENTRYX INC | $496,000 | +165.2% | 83,428 | +231.3% | 0.28% | +188.7% |
| QSII | New | QUALITY SYSTEMS INCput | $247,000 | – | 18,200 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.